KBW upgraded Societe Generale to outperform the broader market with a target price of 32 euros.Association: On December 1-8, the retail sales of new energy market for passenger cars reached 255,000, up 72% compared with the same period of December last year. According to the data of Association, on December 1-8, the retail sales of new energy market for passenger cars reached 255,000, up 72% compared with the same period of December last year and up 3% compared with the same period of last month. Since this year, the cumulative retail sales have reached 9.851 million, up 42% year-on-year. From December 1 to 8, the national passenger car manufacturers wholesale 280,000 new energy vehicles, an increase of 78% compared with the same period in December last year, and an increase of 0% compared with the same period of last month. Since the beginning of this year, the cumulative wholesale has reached 10.997 million vehicles, an increase of 39%.European stocks opened lower, European Stoxx 50 index fell 0.15%, European stocks opened lower, European Stoxx 50 index fell 0.15%, German DAX index fell 0.03%, British FTSE 100 index fell 0.3%, and French CAC40 index fell 0.3%.
The interest rate of active bonds of 10-year and 30-year treasury bonds went down by more than 2bp, and the yield of main inter-bank interest bonds went down. The interest rate of 10-year treasury bonds went down by 2.15bp to 1.82%. The interest rate of 30-year national debt 2400006 fell by 2.15bp to 2.3075%; In 10 years, the interest rate of CDB 240215 dropped by 2.65bp to 1.886%.The Israeli army warned Lebanese residents not to move to southern Lebanon. On the 11th local time, Adrahi, Arabic spokesperson of the Israel Defense Forces, posted a message on the social media platform, asking Lebanese residents not to move to more than 60 villages and their surrounding areas in southern Lebanon until further notice. The Israeli army provided a schematic diagram of the warning area and warned that anyone moving south of the area would put himself in danger. (CCTV News)Guotai Junan expects Hong Kong stocks to fluctuate upward in an N-shaped pattern next year to explore domestic demand and improve investment opportunities. Chen Ximiao, chief analyst of Guotai Junan's overseas strategy, said that looking forward to 2025, the disturbance factors in the Hong Kong stock market from the external environment will continue, and the pace of interest rate cuts by the Federal Reserve under overseas inflation, policy restrictions in areas such as strong US dollar and tariffs, and game friction among big countries will continue. However, the domestic policy thinking is clear, economic expectations are expected to stabilize under the financial impetus, and the profitability of molecular enterprises will improve, and the industrial chain will be able to cope with it. She said that in 2025, the sensitivity of the Hong Kong stock market to external shocks is expected to decline, and more attention should be paid to returning to its own logic. For the trend of Hong Kong stocks in 2025, it is expected to be dominated by the upward pattern of N-shaped shocks, and there are many opportunities for flexibility during the stage. In 2025, we should still actively look for the structure, and focus on the barbell strategy to shift the weight of the two ends. We need to pay more attention to the configuration rhythm and pay attention to the repair opportunities of some domestic products.
It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Molding technology: The transaction amount of selling Jiangsu Bank shares was 226 million yuan. According to the announcement of molding technology, the company sold 25 million shares of Jiangsu Bank through centralized bidding from December 4, 2024 to December 11, 2024, with a transaction amount of 226 million yuan. After the sale, the company also holds 25,000,600 shares of Jiangsu Bank. This transaction is conducive to optimizing the company's asset structure, revitalizing existing assets, improving asset liquidity and efficiency, and meeting the company's capital needs for future development. The sale is expected to have a positive impact on the company's financial position and cash flow.
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide
Strategy guide
12-14
Strategy guide
12-14